© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ADM SARSCV2 BVL 3MCG/0.2ML 3 | Medium Descr | IMM ADMN SARSCOV2 BIVALENT 3 MCG/0.2 ML 3RD | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Procedure or Service, Not Discounted when Multiple | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2024-01-01 | Added | First appearance in codebook. |
| 2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
| 2023-04-18 | Note | AMA guideline changed to include 0171A & 0172A. Published to website 2023-05-01. Received FDA approval effective retroactively to 2023-04-18. |
| 2023-04-18 | Note | These codes (included in the guidelines) are no longer authorized for use in the United States: 0081A, 0082A, 0083A, 91300, 91305, 91307, 91308. |
| 2023-04-18 | Note | Changes made to dosing information |
| 2023-03-14 | Changed | Code change released 2023-03-17. Retroactive to 2023-03-14. Grammatical change only. |
| 2023-01-01 | Deleted | First appearance of code deletion in codebook. |
| 2022-12-09 | Note | CPT codebook guideline includes 91300, 91305, 91307, 91308. 91312, 91315, 0081A, 0082A: Published on AMA website & received FDA approval prior to the addition of 0173A. |
| 2022-12-08 | Added | Published on AMA website 2022-12-09. Received FDA approval effective retroactively to 2022-12-08. |
| 2022-12-08 | Note | CPT codebook guideline added and includes 91317. Published on AMA website December 9, effective 2022-12-08. |
Get instant expert-level medical coding assistance.